Development and validation of an interpretable machine learning model for predicting Philadelphia chromosome-positive acute lymphoblastic leukaemia using clinical and laboratory parameters: a single-centre retrospective study
Objective To develop and validate a prediction model of Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ALL).Design A single-centre retrospective study.Participants This study analysed 471 newly diagnosed patients with ALL at the Second Affiliated Hospital of Army Medical Universi...
Saved in:
| Main Authors: | Jing Zhang, Cheng Zhang, Xi Zhang, Wuchen Yang, Jingya Liu, Yang Gou, Xingqin Huang, Maoshan Chen, Dezhi Huang, Shengwang Wu, Shuiqing Liu, Xiangui Peng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/6/e097526.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The emerging functions and clinical implications of circRNAs in acute myeloid leukaemia
by: Shuiqing Liu, et al.
Published: (2025-04-01) -
A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens
by: Zhen-Yu Xiong, et al.
Published: (2024-12-01) -
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01) -
Relapsed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia responds well to a combination of modified hyper‐CVAD, blinatumomab and tyrosine kinase inhibitor
by: Gaétan Basile, et al.
Published: (2025-02-01) -
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients
by: Jeffrey Baron, et al.
Published: (2024-01-01)